Physician profile
Brandon E Brown
NPI 1235251729
$1,772.18
in general payments reported to CMS, 2019-2025
16 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $381 · 2021: $373 · 2023: $65.73 · 2024: $273 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $405.90 | 2019-2024 | |
| Medtronic, INC. | $309.68 | 2019-2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $191.06 | 2019-2021 | |
| Amgen INC. | $177.98 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.45 | 2020-2021 | |
| Pfizer INC. | $156.88 | 2019-2025 | |
| Fujifilm Healthcare Americas Corporation | $124.97 | 2021 | |
| Shockwave Medical, INC | $68.43 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Janssen Pharmaceuticals, INC | $39.78 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.51 | 2019-2020 | |
| Boston Scientific Corporation | $22.78 | 2023 | Avvigo Guidance System |
| Cordis US Corp. | $18.27 | 2025 | Mynx Control |
| Zoll Medical Corporation | $15.90 | 2024 | Defibrillator |
| Bayer Healthcare Pharmaceuticals INC. | $14.56 | 2025 | |
| Sanofi-Aventis U.S. LLC | $13.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.